首页> 中文期刊> 《转化神经科学电子杂志(英文)》 >Prepulse inhibition deficits in antipsychotic-na-ve first-episode schizophrenia:a meta-analysis

Prepulse inhibition deficits in antipsychotic-na-ve first-episode schizophrenia:a meta-analysis

         

摘要

Objective:Published studies have found prepulse inhibition(PPI)in schizophrenia is impaired,suggesting PPI may be a biomarker of schizophrenia.We aim to examine whether PPI deficits exist in antipsychotic-na-ve,first-episode schizophrenia,and evaluate the effect size of PPI deficits between patients and healthy controls.Methods:The effect size of PPI deficits was evaluated for PPI%by calculating standard mean differences(SMDs)between patients with antipsychotic-na-ve,first-episode schizophrenia and healthy controls.Results:Twelve studies met the inclusion criteria,consisting390antipsychotic-na-ve,first-episode schizophrenia and406healthy controls.The effect sizes of76dB PPI in60ms and120ms interstimulus interval(ISI)were-0.19and-0.41respectively,and the76dB PPI overall effect size was-0.30.The effect sizes of85/86dB PPI in30ms,60ms and120ms ISI were-0.25,-0.42and-0.59respectively,and the85/86dB PPI overall effect size was-0.46.One study were excluded due to heterogeneity in the85/86dB,120ms ISI group,the pooled effect size of the PPI differences between patient group and health control dropped to-0.42,and the overall effect size changed to-0.39.There were no statistical differences in startle magnitude(overall effect size=-0.18)and habituation%(overall effect size=-0.17)between patients and healthy controls.Conclusions:Antipsychotic-na-ve,first-episode schizophrenia patients exhibit robust and reliable deficits in PPI,85/86dB PPI deficit was more severe than76dB PPI,and85/86dB,60-ms ISI PPI was more likely to be a biomarker for schizophrenia,it suggested that the parameters of PPI are particularly significant to affect the effect size so that should be interpreted with cautions in the future studies.

著录项

  • 来源
    《转化神经科学电子杂志(英文)》 |2018年第2期|P.23-34|共12页
  • 作者单位

    [1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;

    Beijing Anding Hospital;

    Capital Medical University;

    Beijing 100088;

    China;

    [1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;

    Beijing Anding Hospital;

    Capital Medical University;

    Beijing 100088;

    China;

    [1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;

    Beijing Anding Hospital;

    Capital Medical University;

    Beijing 100088;

    China;

    [1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;

    Beijing Anding Hospital;

    Capital Medical University;

    Beijing 100088;

    China;

    [2]Department of Psychiatry and Behavioral Sciences;

    Emory University School of Medicine;

    Atlanta 30322;

    USA;

    [3]Mental Health Service Line;

    Atlanta VA Medical Center;

    Decatur 30033;

    USA;

    [1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;

    Beijing Anding Hospital;

    Capital Medical University;

    Beijing 100088;

    China;

  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 医药、卫生;
  • 关键词

    prepulse inhibition(PPI); antipsychotic-na-ve; first-episode schizophrenia; patients; meta-analysis;

    机译:前脉冲抑制(PPI);初次使用抗精神病药;首发精神分裂症;患者;元分析;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号